NEUROENDOCRINE TUMOR A021602
Study #A021602Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Prior Therapy
Back To Clinical Trials NCI Database Entry
Randomized, Double-Blinded Phase III Study of Cabozantinib Versus Placebo in Patients with Advanced Neuroendocrine Tumors after Progression on Prior Therapy
Back To Clinical Trials NCI Database Entry